glp 1 competitors GLP-1 Costs Explained: Managing Coverage Challenges The Race Is On: Winning

Skipping variety could leave you missing out on key nutrients your body needs

Even with many unknowns, savvy employers are thinking more deliberately about whether their benefits strategy is built to hold up over time

GLP-1 agonists resist this breakdown, staying active for hours

William Yi, MD OrderlyMeds Medical Expert In this clip from our GLP-1 Side Effects webinar, Dr

[DOI] [PMC free article] [PubMed] [Google Scholar] 202.Sadry SA, Drucker DJ

In contrast, short-acting formulations such as exenatide and the older-generation agent lixisenatide are now prescribed far less frequently, and several formulations have been withdrawn from the market in certain countries, largely due to limited clinical uptake, the availability of more effective long-acting alternatives, and commercial considerations rather than confirmed safety concerns